Collegium Pharmaceutical
COLL
COLL
124 hedge funds and large institutions have $492M invested in Collegium Pharmaceutical in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 47 increasing their positions, 35 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
7% less funds holding
Funds holding: 133 → 124 (-9)
29% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 28
33% less capital invested
Capital invested by funds: $739M → $492M (-$247M)
Holders
124
Holding in Top 10
3
Calls
$6.12M
Puts
$948K
Top Buyers
| 1 | +$19.2M | |
| 2 | +$12.9M | |
| 3 | +$5.12M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$4.56M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$3.39M |
Top Sellers
| 1 | -$6.99M | |
| 2 | -$6.97M | |
| 3 | -$5.43M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$5M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$3.72M |